What causes elevated Dehydroepiandrosterone (DHEA) sulfate levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Elevated DHEA Sulfate Levels

The most common causes of elevated dehydroepiandrosterone sulfate (DHEAS) levels include non-classical congenital adrenal hyperplasia, polycystic ovary syndrome (PCOS), adrenal tumors, and certain genetic variants affecting DHEAS metabolism or transport. 1

Primary Causes

Congenital Adrenal Hyperplasia

  • Non-classical congenital adrenal hyperplasia should be ruled out in patients with elevated DHEAS, particularly when levels exceed age-specific thresholds (>3800 ng/ml for ages 20-29, >2700 ng/ml for ages 30-39) 1
  • Patients with poorly controlled congenital adrenal hyperplasia due to 21-hydroxylase deficiency may have normal or elevated DHEAS levels 2
  • Adequately treated patients with congenital adrenal hyperplasia typically show suppressed DHEAS levels 2

Adrenal Tumors

  • Very high DHEAS levels are typically associated with adrenal tumors 3
  • Diagnostic workup should include imaging studies (ultrasonography, MRI) to exclude adrenal masses when DHEAS levels are significantly elevated 3
  • Dexamethasone suppression testing can help differentiate between functional causes and tumors 4

Polycystic Ovary Syndrome (PCOS)

  • Approximately 20-30% of women with PCOS demonstrate excess adrenal precursor androgen production, with elevated DHEAS as a marker 5
  • PCOS patients with elevated DHEAS appear to have a generalized exaggeration in adrenal steroidogenesis in response to ACTH stimulation 5
  • The pathogenesis involves acceleration of pulsatile gonadotropin-releasing hormone secretion, insulin resistance, and downstream metabolic dysregulation 1

Cushing's Disease

  • Patients with Cushing's disease (ACTH-dependent Cushing's syndrome) typically have normal or elevated DHEAS levels 6
  • In contrast, patients with adrenal adenomas causing Cushing's syndrome usually have suppressed DHEAS levels 6
  • ACTH appears to be the major determinant of DHEAS secretion 6

Genetic and Transport-Related Causes

  • Genetic variants affecting steroid sulfatase (STS) can lead to impaired DHEAS metabolism 3
  • Mutations in transporter proteins, such as breast cancer-resistance protein (BCRP), may affect DHEAS efflux and contribute to elevated levels 3
  • Combinations of heterozygous mutations in both STS and BCRP genes have been associated with very high DHEAS levels 3

Diagnostic Approach

Initial Evaluation

  • Assess for clinical signs of hyperandrogenism: hirsutism, acne, menstrual irregularities, androgenetic alopecia, infertility 1
  • In prepubertal children, look for early-onset body odor, axillary or pubic hair, accelerated growth, advanced bone age, and genital maturation 1
  • In postpubertal females, evaluate for infrequent menses, hirsutism, androgenetic alopecia, infertility, polycystic ovaries, clitoromegaly, and truncal obesity 1

Laboratory Testing

  • A typical hormone-screening panel should include free and total testosterone, DHEAS, androstenedione, luteinizing hormone, and follicle-stimulating hormone 1
  • Consider additional testing for growth hormone, insulin-like growth factor, lipid levels, insulin, sex hormone binding globulin, free androgen index, prolactin, estrogen, and progesterone in selected cases 1
  • Rule out non-classical congenital adrenal hyperplasia with appropriate testing 1

Imaging Studies

  • Pelvic ultrasound may be indicated to evaluate for polycystic ovaries in females 1
  • Adrenal imaging (CT or MRI) should be considered when DHEAS levels are very high to exclude adrenal tumors 3, 4

Clinical Implications

  • Elevated DHEAS levels may be protective against cardiovascular risk in the general population, though the role in PCOS patients remains unclear 5
  • Identifying the underlying cause of elevated DHEAS is important for appropriate management and treatment of associated conditions 1
  • In patients with suspected hypercortisolism, measuring plasma aldosterone and renin activity is important to evaluate for concomitant hyperaldosteronism 7

By systematically evaluating patients with elevated DHEAS levels and considering these potential causes, clinicians can determine the appropriate diagnostic workup and management strategy.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

DHEA, DHEAS and PCOS.

The Journal of steroid biochemistry and molecular biology, 2015

Research

Serum dehydroepiandrosterone sulfate in Cushing's syndrome.

The Journal of clinical endocrinology and metabolism, 1984

Guideline

Hypercortisolism and Hyperaldosteronism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.